We serve Chemical Name:methyl O6-benzoyl-β-D-glucoside CAS:21056-50-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl O6-benzoyl-β-D-glucoside
CAS.NO:21056-50-8
Synonyms:methyl-(O6-benzoyl-β-D-glucopyranoside);Methyl-6-O-benzoyl-β-D-glucopyranosid;Benzoic acid (2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxy-tetrahydro-pyran-2-ylmethyl ester;methyl 6-O-benzoyl-β-D-glucopyranoside;Methyl-(O6-benzoyl-β-D-glucopyranosid)
Molecular Formula:C14H18O7
Molecular Weight:298.28900
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:105.45000
Exact Mass:298.10500
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like methyl-(O6-benzoyl-β-D-glucopyranoside) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl-(O6-benzoyl-β-D-glucopyranosid) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzoic acid (2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methoxy-tetrahydro-pyran-2-ylmethyl ester Use and application,Methyl-(O6-benzoyl-β-D-glucopyranosid) technical grade,usp/ep/jp grade.
Related News: The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. methyl O6-benzoyl-β-D-glucoside manufacturer The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. methyl O6-benzoyl-β-D-glucoside supplier In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. methyl O6-benzoyl-β-D-glucoside vendor In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. methyl O6-benzoyl-β-D-glucoside factory In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. methyl O6-benzoyl-β-D-glucoside manufacturer The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. methyl O6-benzoyl-β-D-glucoside supplier In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. methyl O6-benzoyl-β-D-glucoside vendor In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. methyl O6-benzoyl-β-D-glucoside factory In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers.